Open AccessBRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE
Author(s) -
О М Курбачева,
S A Polner,
Д. С. Смирнов
Publication year - 2014
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja499
Subject(s) - asthma , bronchodilator , medicine , anticholinergic , inhaler , anticholinergic agents , tiotropium bromide , bronchodilator agents , intensive care medicine , pathogenesis , anesthesia , lung function , lung
In this article the problems of improving the control of bronchial asthma through optimization of bronchodilator therapy are discussed. Cholinergic mechanisms in the pathogenesis of asthma and the possibilities of use of long-acting m-anticholinergic - tiotropium (via liquid inhaler R espimat) - in the treatment of this disease are shown. Pharmacological properties of bronchodilators are discussed to identify the main groups of patients who need tiotropium therapy.